Results 151 to 160 of about 3,185 (196)

Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies. [PDF]

CNS Drugs
Dzamko N.
europepmc   +1 more source

Synuclein Disorder-Related Genetic Determinants of Mild Behavioural Impairment in a Pre-Clinical Community Cohort. [PDF]

Int J Geriatr Psychiatry
Sander-Long M, Creese B, Corbett A, Rosenzweig I, Cummings J, Ballard C.   +5 more
europepmc   +1 more source

Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients. [PDF]

Hum Mol Genet
Kumar M, Feldman RA.
europepmc   +1 more source

Progression of <i>GBA1</i> severe and risk variants: a longitudinal mixed model analysis. [PDF]

Front Aging Neurosci
Hanff AM, McCrum C, Rauschenberger A, Pachchek S, Aguayo GA, Pauly C, Jónsdóttir SR, Tsurkalenko O, Pauly L, Landoulsi Z, Leist AK, May P, Zeegers MP, Krüger R.   +13 more
europepmc   +1 more source

Editorial: Genetic underpinnings of Alzheimer's and Parkinson's: insights and innovations. [PDF]

Front Genet
Marongiu R, Cordato D, Reiss AB.
europepmc   +1 more source

Plasma Glucosylsphingosine in GBA1 E365K, N409S, and L483P Heterozygous Mutation Carriers. [PDF]

Mov Disord
Agin-Liebes J, Haimovich A, Griep R, Hatcher NG, Yao L, Waters C, Padmanabhan S, Alcalay RN.   +7 more
europepmc   +1 more source

The genetic architecture of Parkinson's disease on the Island of Crete. [PDF]

NPJ Parkinsons Dis
Boura I, Sait S, Marinakis NM, Arvind K, Chia R, Ray A, Vatsellas G, Loupis T, Pavlaki V, Makrythanasis P, Mitsias P, Xiromerisiou G, Scholz SW, Spanaki C.   +13 more
europepmc   +1 more source

The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism. [PDF]

Mov Disord
Henderson MJ, Chen TC, Glasstetter LM, Chen Y, Marugan JJ, Sidransky E.   +5 more
europepmc   +1 more source

Mutations in the GBA1, LRRK2, TMEM175, PARK2, PINK1, and PARK7 genes lead to sex-specific serum metabolic changes in patients with Parkinson's disease

Sex differences significantly influence the pathophysiology of Parkinson's disease (PD). However, it remains unclear whether sex differences affect blood metabolome profiles in patients with PD-related gene mutations compared to healthy controls (HCs). Here, we conducted a 1H-Nuclear Magnetic Resonance (NMR) metabolomic analysis of serum samples from a
openaire   +1 more source

Transcriptional changes in the peripheral blood of at-risk individuals without clinical manifestation of Parkinson’s Disease

Whittle B, Chen C, Izuogu O, Jackson M, Santibanez-Koref M, Hudson G.   +5 more
europepmc   +1 more source